Protagonist Therapeutics Inc Share Price Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Sales 2024 * | 270M 0 21.27B | Sales 2025 * | 120M 0 9.44B | Capitalization | 1.85B 0 145B |
---|---|---|---|---|---|
Net income 2024 * | 77M - 6.07B | Net income 2025 * | 2M - 158M | EV / Sales 2024 * | 5.2 x |
Net cash position 2024 * | 442M 0 34.79B | Net cash position 2025 * | 677M 0 53.36B | EV / Sales 2025 * | 9.76 x |
P/E ratio 2024 * |
27.3
x | P/E ratio 2025 * |
-32
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Protagonist Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 17/04/22 |
Chief Tech/Sci/R&D Officer | - | 30/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 07/06/17 |
Harold Selick
CHM | Chairman | 69 | 31/01/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 25/10/23 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |